The co-overexpression of c-Myc and Bcl-2 proteins detected by immunohistochemistry (IHC) defines double-expressor lymphoma (DEL), representing 20%–30% of newly diagnosed DLBCL cases (2, 3). This evidence concerns the gene MYC and diffuse large B-cell lymphoma.